American Diabetes Association
2 files

A Qualitative Study of Barriers to Medication-Taking Among People With Type 2 Diabetes Using the Theoretical Domains Framework

posted on 2024-03-05, 15:46 authored by Michael Vallis, Susie Jin, Agnieszka Klimek-Abercrombie, Ginnie Ng, Noah M. Ivers

Objective. We aimed to better understand the challenges related to type 2 diabetes medication-taking through Theoretical Domains Framework (TDF)-guided interviews with people with type 2 diabetes with varying degrees of medication-taking.

Methods. One-on-one qualitative interviews following a semi-structured discussion guide informed by the TDF were conducted. Thirty people with type 2 diabetes in Canada were interviewed, with representation from across the country, of both sexes (47% female), of people with various diabetes durations (mean 12.9 ± 7.9 years), with different types of medication plans (n = 15 on polypharmacy), and with various medication-taking levels (n = 10 each for low-, medium-, and high-engagement groups).

Results. Themes related to medication-taking from interviews mapped to 12 of the 14 TDF theme domains, with the exclusion of the knowledge and skills domains. The most prominent domains, as determined by high-frequency themes or themes for which people with low and high medication-taking had contrasting perspectives were 1) emotion, 2) memory, attention, and decision processes, 3) behavioral regulation, 4) beliefs about consequences, 5) goals, and 6) environmental context and resources.

Conclusion. Through our interviews, several areas of focus emerged that may help efforts to increase medication-taking. To validate these findings, future quantitative research is warranted to help support people with type 2 diabetes in overcoming psychological and behavioral barriers to medication-taking.


Novo Nordisk > Novo Nordisk Canada


Usage metrics

    Diabetes Spectrum


    Ref. manager